Bottom line
What does IBB hold?
IBB held 254 positions as of Sep 30, 2025. Its largest holding is BlackRock Funds III at 13.18% of the fund, and the top 10 positions add up to 59%. By asset type it is 100% stocks, 13% cash & short-term funds.
Updated Jul 13, 2026
IBB top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | BlackRock Funds III BlackRock Cash Funds: Institutional, SL Agency Shares |
Cash & short-term funds | 13.18% | $783.1M |
| 2 | Vertex Pharmaceuticals, Inc. | Stocks | 7.66% | $455.3M |
| 3 | Gilead Sciences, Inc. | Stocks | 7.52% | $446.5M |
| 4 | Amgen, Inc. | Stocks | 7.50% | $445.8M |
| 5 | Regeneron Pharmaceuticals, Inc. | Stocks | 5.70% | $338.6M |
| 6 | Alnylam Pharmaceuticals, Inc. | Stocks | 5.68% | $337.5M |
| 7 | IQVIA Holdings, Inc. | Stocks | 3.18% | $188.7M |
| 8 | Argenx SE | Stocks | 3.15% | $187.1M |
| 9 | Insmed, Inc. | Stocks | 2.95% | $175.5M |
| 10 | Mettler-Toledo International, Inc. | Stocks | 2.49% | $148.0M |
| 11 | Natera, Inc. | Stocks | 2.11% | $125.6M |
| 12 | BeOne Medicines Ltd. | Stocks | 2.11% | $125.2M |
| 13 | Biogen, Inc. | Stocks | 2.03% | $120.9M |
| 14 | United Therapeutics Corp. | Stocks | 1.82% | $108.1M |
| 15 | Waters Corp. | Stocks | 1.77% | $105.0M |
| 16 | Incyte Corp. | Stocks | 1.62% | $96.5M |
| 17 | Illumina, Inc. | Stocks | 1.41% | $83.7M |
| 18 | Genmab A/S | Stocks | 1.38% | $81.9M |
| 19 | Neurocrine Biosciences, Inc. | Stocks | 1.34% | $79.9M |
| 20 | Medpace Holdings, Inc. | Stocks | 1.16% | $68.8M |
| 21 | Exelixis, Inc. | Stocks | 1.07% | $63.5M |
| 22 | Ionis Pharmaceuticals, Inc. | Stocks | 1.03% | $61.0M |
| 23 | BioMarin Pharmaceutical, Inc. | Stocks | 1.02% | $60.4M |
| 24 | Madrigal Pharmaceuticals, Inc. | Stocks | 0.92% | $54.5M |
| 25 | Moderna, Inc. | Stocks | 0.88% | $52.3M |
Source: SEC Form N-PORT, period ended Sep 30, 2025, filed Jul 13, 2026